A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.

We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

Shares of Bristol Myers Squibb Co. BMY advanced 1.90% to $60.02 Friday, on what proved to be an all-around dismal trading ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in psoriatic arthritis (PsA), the company has presented detailed data from ...

Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical industry company. In the fourth quarter of 2024, the company reported revenue of $12.34 billion, reflecting a 7.5% increase ...